menu
    • menu

    Company profile for Audentes Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a clinical stage company developing a compelling portfolio of innovative AAV-based genetic medicines for people with serious rare neuromuscular diseases. We see the patient community as our partners, collaborators, and teachers. We leverage our AAV gene therapy technology platform and proprietary manufacturing expertise to progress programs across three modalities: gene replacement, vectorized exon skipping, and vectori...
    We are a clinical stage company developing a compelling portfolio of innovative AAV-based genetic medicines for people with serious rare neuromuscular diseases. We see the patient community as our partners, collaborators, and teachers. We leverage our AAV gene therapy technology platform and proprietary manufacturing expertise to progress programs across three modalities: gene replacement, vectorized exon skipping, and vectorized RNA knockdown. We use a focused set of criteria to select target indications, which we believe increases the chances of success for each of our programs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Audentes TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    600 California Street, 17th Floor San Francisco, CA 94108
    Telephone
    Telephone
    (415) 818-1001
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.audentestx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/audentes-therapeutics
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/audentestx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Astellas writes down another piece of its Audentes gene therapy acquisition
    Astellas writes down another piece of its Audentes gene therapy acquisition

    16 Apr 2024

    // Amber Tong ENDPTS

    https://endpts.com/astellas-books-450m-writedown-on-preclinical-gene-therapy-anemia-drug/

    Amber Tong ENDPTS
    16 Apr 2024
    Share Share
    FDA lifts clinical hold on Astellas Pompe gene therapy
    FDA lifts clinical hold on Astellas Pompe gene therapy

    21 Jan 2023

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/astellas-after-years-gene-therapy-woes-gets-rare-boost-fda-lifting-pompe-clinical-hold#:~:text=The%20FDA%20has%20handed%20a,participant%20developed%20peripheral%20sensory%20neuropathy

    Nick Paul Taylor FIERCE BIOTECH
    21 Jan 2023
    Share Share
    Astellas takes $540M impairment charge over Audentes' gene therapy trial hold
    Astellas takes $540M impairment charge over Audentes' gene therapy trial hold

    28 Apr 2021

    // Ben Adams FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/astellas-takes-540m-impairment-charge-over-audentes-gene-therapy-trial-hold

    Ben Adams FIERCE BIOTECH
    28 Apr 2021
    Share Share
    Audentes Becomes Astellas Gene Therapies, Will Advance MD Treatments
    Audentes Becomes Astellas Gene Therapies, Will Advance MD Treatments

    02 Apr 2021

    // Marta Figueiredo PhD MUSCULARDYSTROPHYNEWS

    https://musculardystrophynews.com/2021/04/06/audentes-becomes-astellas-gene-therapies-will-advance-treatments-for-muscular-dystrophy-md-other-conditions/

    Marta Figueiredo PhD MUSCULARDYSTROPHYNEWS
    02 Apr 2021
    Share Share
    Audentes CEO exits as Astellas rebrands a gene therapy buyout
    Audentes CEO exits as Astellas rebrands a gene therapy buyout

    01 Jan 2021

    // Ned Pagliarulo BIOPHARMADIVE

    https://www.biopharmadive.com/news/astellas-gene-therapy-audentes-holles-depart/597703/

    Ned Pagliarulo BIOPHARMADIVE
    01 Jan 2021
    Share Share
    Audentes sees FDA hold lifted after 3 trial deaths
    Audentes sees FDA hold lifted after 3 trial deaths

    31 Dec 2020

    // Ben Adams FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/takeda-audentes-see-fda-hold-lifted-after-three-trial-deaths-blighted-3b-program

    Ben Adams FIERCE BIOTECH
    31 Dec 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search